BPC-157/TB-500 Blend (Wolverine Blend): Research Overview

The BPC-157/TB-500 Blend — commonly referred to as the Wolverine Blend in research settings — combines two well-studied repair-associated peptides into a single formulation. BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide derived from gastric juice protein, while TB-500 is a synthetic analogue of Thymosin Beta-4 (Tβ4), a ubiquitous cellular protein involved in actin dynamics and tissue repair. Researchers have shown interest in the combination for its potentially complementary mechanisms, each targeting overlapping but distinct pathways in wound healing and tissue regeneration.

Mechanism of Action

BPC-157 exerts its effects through nitric oxide signaling, VEGF pathway modulation, and growth hormone receptor upregulation, supporting angiogenesis and direct tissue cytoprotection. TB-500 (Thymosin Beta-4 analogue) works primarily by sequestering G-actin monomers, which regulates actin polymerization and cellular motility — processes critical for cell migration into wound sites, tissue remodeling, and inflammatory resolution. Together, the blend targets both vascular support (via BPC-157) and cytoskeletal reorganization (via TB-500), potentially offering complementary activity across different phases of tissue repair.

Key Research Areas

• Soft Tissue Repair Models: Preclinical studies have investigated both compounds individually in tendon, ligament, and muscle injury models; the blend is being explored for potential additive effects in these contexts.
• Vascular and Angiogenic Research: BPC-157’s VEGF interactions and TB-500’s role in endothelial cell migration have prompted interest in combined vascular repair models.
• Inflammation Resolution: Research has examined both compounds’ ability to modulate inflammatory cytokines at injury sites, with the blend explored for combined anti-inflammatory activity.
• Neurological Repair: Both peptides have been studied individually in peripheral and central nervous system damage models; combination research is an emerging area.

Research Applications

The Wolverine Blend is used in preclinical research settings where the combined activity of BPC-157 and TB-500 is being evaluated. Animal models of acute and chronic tissue injury are the primary research application, with subcutaneous or intraperitoneal administration protocols commonly described in the literature. The blend is also used as a convenient delivery format in studies examining multi-peptide formulations and their pharmacokinetic and pharmacodynamic interactions.

Study Protocol Context

BPC-157 animal studies provide the most detailed protocol data for the compounds in this blend. In tendon and muscle repair models, researchers consistently used once-daily intraperitoneal administration at 10 µg/kg or 10 ng/kg, with study durations ranging from 14 days (Staresinic et al., 2003, PMID 14554208) to 21 days (Krivic et al., 2006, PMID 16583442) and up to 72 days for longer recovery models (Staresinic et al., 2006, PMID 16609979). The first dose in these studies was administered within 30 minutes of surgically induced injury.

Published research on Thymosin Beta-4 — the naturally occurring protein TB-500 is modeled after — examined topical and systemic administration in wound healing and cardiac repair models. Wound healing studies by Malinda et al. (1999) and Philp et al. (2003) demonstrated significant tissue repair activity in rodent models using both routes, with study durations in the 1–4 week range. Per-kilogram dosing specifics for Thymosin Beta-4 varied by study and application.

These protocol details are provided as scientific reference only and do not represent dosing guidance for any application.

Storage and Handling

This blend is supplied as a co-lyophilized powder in a single vial. Store at -20°C, away from light and moisture. Reconstitute with sterile bacteriostatic water under aseptic conditions. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles to maintain integrity of both peptide components.

Available from Alpha Peptides US

Alpha Peptides US offers the BPC-157/TB-500 Blend 10mg/10mg (Wolverine Blend) for qualified research applications. Each vial contains both peptides in a single convenient formulation.

This product is intended for laboratory research purposes only. It is not approved by the FDA and is not intended for human or veterinary use, diagnosis, treatment, or prevention of any condition.